Athene Stock Forecast, Price & News

Athene (NYSE:ATH) Frequently Asked Questions

Is Athene a buy right now?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Athene in the last twelve months. There are currently 12 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" Athene stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ATH, but not buy additional shares or sell existing shares.
View analyst ratings for Athene or view top-rated stocks.

What stocks does MarketBeat like better than Athene?

Wall Street analysts have given Athene a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Athene wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Athene's next earnings date?

Athene is scheduled to release its next quarterly earnings announcement on Wednesday, November 3rd 2021.
View our earnings forecast for Athene.

How can I listen to Athene's earnings call?

Athene will be holding an earnings conference call on Wednesday, November 3rd at 10:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 402-220-7207 with passcode "ATHQ321".

How were Athene's earnings last quarter?

Athene Holding Ltd. (NYSE:ATH) released its quarterly earnings data on Wednesday, August, 4th. The insurance provider reported $5.04 earnings per share for the quarter, beating the consensus estimate of $3.40 by $1.64. The insurance provider had revenue of $1.73 billion for the quarter, compared to analysts' expectations of $1.55 billion. Athene had a net margin of 16.61% and a trailing twelve-month return on equity of 14.06%.
View Athene's earnings history.

How has Athene's stock been impacted by COVID-19 (Coronavirus)?

Athene's stock was trading at $31.16 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, ATH stock has increased by 187.2% and is now trading at $89.48.
View which stocks have been most impacted by COVID-19.

What price target have analysts set for ATH?

13 brokers have issued twelve-month price objectives for Athene's stock. Their forecasts range from $50.00 to $83.00. On average, they anticipate Athene's share price to reach $65.48 in the next year. This suggests that the stock has a possible downside of 26.8%.
View analysts' price targets for Athene or view top-rated stocks among Wall Street analysts.

Who are Athene's key executives?

Athene's management team includes the following people:

• James R. Belardi, Chairman, Chief Executive & Investment Officer
• Bill Wheeler, President
• Marty Klein, Chief Financial Officer & Executive Vice President (LinkedIn Profile)
• Randy Epright, Chief Information Officer & Executive VP
• Michael S. Downing, Executive Vice President & Chief Actuary

Who are some of Athene's key competitors?

Some companies that are related to Athene include AXA (AXAHY), MetLife (MET), Prudential (PUK), China Life Insurance (LFC), Prudential Financial (PRU), Manulife Financial (MFC), Sun Life Financial (SLF), Swiss Re (SSREY), Aviva (AVVIY), Legal & General Group (LGEN), Lincoln National (LNC), Aegon (AEG), Sony Financial (SNYFY), Globe Life (GL) and Reinsurance Group of America (RGA).
View all of ATH's competitors.

What other stocks do shareholders of Athene own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Athene investors own include DocuSign (DOCU), AT&T (T), Alibaba Group (BABA), Intel (INTC), Applied Materials (AMAT), JD.com (JD), Okta (OKTA), Visa (V), Slack Technologies (WORK) and AbbVie (ABBV).

When did Athene IPO?

(ATH) raised $952 million in an IPO on Friday, December 9th 2016. The company issued 23,800,000 shares at $38.00-$42.00 per share. Goldman Sachs, Barclays, Citigroup and Wells Fargo Securities served as the underwriters for the IPO and BofA Merrill Lynch, BMO Capital Markets, Credit Suisse, Deutsche Bank Securities, J.P. Morgan, Morgan Stanley, RBC Capital Markets, BNP PARIBAS, BTIG, Evercore ISI, SunTrust Robinson Humphrey, UBS Investment Bank, Apollo Global Securities, Dowling & Partners Securities, Keefe, Bruyette & Woods (A Stifel Company), Lazard, Raymond James, Rothschild, Sandler O’Neill + Partners and The Williams Capital Group, L.P. were co-managers.

What is Athene's stock symbol?

Athene trades on the New York Stock Exchange (NYSE) under the ticker symbol "ATH."

Who are Athene's major shareholders?

Athene's stock is owned by many different retail and institutional investors. Top institutional investors include Gofen & Glossberg LLC IL (0.08%), Oregon Public Employees Retirement Fund (0.02%), DNB Asset Management AS (0.02%), IFM Investors Pty Ltd (0.01%), Rothschild Investment Corp IL (0.01%) and Strs Ohio (0.01%). Company insiders that own Athene stock include Frank Lauren Gillis, Grant Kvalheim, H Carl Mccall, James Richard Belardi, John Leonard Golden, Lawrence Ruisi, Marc A Beilinson, Marc J Rowan, Marc J Rowan, Marc Ostryniec, Martin P Klein and Robert L Borden.
View institutional ownership trends for Athene.

Which institutional investors are selling Athene stock?

ATH stock was sold by a variety of institutional investors in the last quarter, including Gofen & Glossberg LLC IL, Strs Ohio, and Rothschild Investment Corp IL. Company insiders that have sold Athene company stock in the last year include H Carl Mccall, John Leonard Golden, Marc J Rowan, Marc Ostryniec, Martin P Klein, and Robert L Borden.
View insider buying and selling activity for Athene or view top insider-selling stocks.

Which institutional investors are buying Athene stock?

ATH stock was purchased by a variety of institutional investors in the last quarter, including IFM Investors Pty Ltd, Sphinx Trading LP, DekaBank Deutsche Girozentrale, Kestra Advisory Services LLC, Oregon Public Employees Retirement Fund, DNB Asset Management AS, FNY Investment Advisers LLC, and Toth Financial Advisory Corp. Company insiders that have bought Athene stock in the last two years include Grant Kvalheim, James Richard Belardi, Marc A Beilinson, and Martin P Klein.
View insider buying and selling activity for Athene or or view top insider-buying stocks.

How do I buy shares of Athene?

Shares of ATH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Athene's stock price today?

One share of ATH stock can currently be purchased for approximately $89.48.

How much money does Athene make?

Athene has a market capitalization of $17.16 billion and generates $14.76 billion in revenue each year. The insurance provider earns $1.54 billion in net income (profit) each year or $6.42 on an earnings per share basis.

How many employees does Athene have?

Athene employs 1,350 workers across the globe.

What is Athene's official website?

The official website for Athene is www.athene.com.

Where are Athene's headquarters?

Athene is headquartered at 96 Pitts Bay Road, Pembroke D0, HM08.

How can I contact Athene?

Athene's mailing address is 96 Pitts Bay Road, Pembroke D0, HM08. The insurance provider can be reached via phone at (441) 279-8400 or via email at [email protected].